Content
How to Acknowledge NCIBC in your publications and presentations
For all center members: Please include the Nebraska Center for Integrated Biomolecular Communication as an affiliation along with your home department in your publications.
Example:
- Department of Chemistry
- Nebraska Center for Integrated Biomolecular Communication, University of Nebraska-Lincoln, Lincoln, Nebraska, 68588, United States
For projects directly funded by NCIBC: Please acknowledge the award or awards that supported the research: “Research reported in this publication was supported by the National Institute of General Medical Sciences of the National Institutes of Health under Award Number P20GM113126 and/or P30GM165288.” Include only the applicable award number, or both numbers if both Phase 2 and Phase 3 supported the work.
For projects using NCIBC core services: Please acknowledge the relevant core or service and the award or awards that supported its use: “This work was supported by the Nebraska Center for Integrated Biomolecular Communication, [insert relevant core or service name], through the National Institute of General Medical Sciences of the National Institutes of Health under Award Number P20GM113126 and/or P30GM165288.” Include only the applicable award number, or both numbers if services supported by both awards contributed to the work.
Award periods: P20GM113126 is the NCIBC Phase 2 award and is currently in a no-cost extension from August 1, 2026, through July 31, 2027. P30GM165288 is the NCIBC Phase 3 award, which began July 10, 2026. Because the awards overlap, please contact the NCIBC Administrative Core if you are unsure which award number applies.
For all publications affiliated with or acknowledging the NCIBC grant number(s): We are required to deposit the accepted article with the NIH in NCBI. If you do not know how to do this, please ask NCIBC Administrative Core for assistance. It is required!
IMPORTANT REMINDER FOR ALL CENTER MEMBERS: COBRE support cannot be used for research that includes foreign components. Collaborations with investigators at a foreign site anticipated to result in co-authorship constitutes a foreign component. If such components are involved, NIH prior approval is required.
For FY 2026:
- If there are any publications with a foreign co-author, a statement submitted through the Signing Official (SO) confirming the author will no longer publish or collaborate with the foreign partner is sufficient to show the collaboration has ended. Also indicate that no IDeA money was transferred via subcontract to an institution in a foreign country. This path will minimize delays.
For FY2027 onward:
- PIs are required to submit prior approval requests for any publication co-authored with individual(s) affiliated with a foreign institution(s).
- Per NOT-OD-26-026, prior approval requests must be initiated and submitted by a SO for the recipient organization.
- In addition to noting the foreign site and the name of the foreign investigator, the prior approval request should provide information about the nature of the research being conducted; why the involvement of the foreign site is necessary; and whether any data will be transferred.
Program Director/Principal Investigator (PD/PI) of IDeA grant assumes responsibility for ensuring that the grant:
- Aligns with NIH priorities
- Complies with the Notice of Grant Award
- Meets all Notice of Funding Opportunity requirements including that foreign components, as defined in the NIH Grants Policy Statement, are not allowed. Collaborations with investigators at a foreign site anticipated to result in co-authorship constitutes a foreign component.
Questions? Email: knelkinpedersen2@unl.edu